The board of Johnson Pharmacare, on Friday, 18 February 2022, approved and recommended the issuance of fully paid-up bonus shares in the ratio of 1:10 (i.e. one fully paid up equity share for every ten fully paid up equity share held).
During pre-bonus issue, the paid up equity share capital stood at Rs 50 crore, consisting of 50 crore equity shares of Rs 1 each. Post bonus issue, the paid up equity share capital will be Rs 55 crore, consisting of 55 crore equity shares of Rs 1 each.
Last month, the company had said that its board would consider bonus share issue on 18 February 2022.
On a standalone basis, Johnson Pharmacare reported a net loss of Rs 0.03 crore in Q3 FY22 as compared to a net loss of Rs 0.05 crore in Q3 FY21.
Johnson Pharmacare is in the business of wholesale and retail trade all kinds of pharmaceuticals. It is also engaged in the business of chemists, druggists, buyers, sellers, agents, distributors and stockiest of all kinds of pharmaceuticals and allied products.
Shares of Johnson Pharmacare skid 4.44% to Rs 1.29 on BSE.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app